Ulrike Friedrich Selected Research

Protein Deficiency

4/2011

Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrike Friedrich Research Topics

Disease

3	Retinoschisis (Retinoschisis, Juvenile) 01/2019 - 03/2011
3	Neoplasms (Cancer) 11/2015 - 10/2003
2	Macular Degeneration (Age-Related Maculopathy) 12/2020 - 04/2011
2	Carcinogenesis 12/2003 - 11/2003
1	Retinal Dystrophies 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Protein Deficiency 04/2011
1	Crohn Disease (Crohn's Disease) 12/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2003
1	Adenocarcinoma 12/2003
1	Ulcerative Colitis 12/2003
1	Embryonal Rhabdomyosarcoma 11/2003
1	Sarcoma (Soft Tissue Sarcoma) 11/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2011
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2003 - 10/2003
2	Messenger RNA (mRNA)IBA 04/2011 - 11/2003
1	hyaluronate lyase (spreading factor)IBA 12/2020
1	VitronectinIBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	CuprizoneIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Serine Proteases (Serine Protease)IBA 11/2015
1	Serine (L-Serine)FDA Link 04/2011
1	Peptide Hydrolases (Proteases)FDA Link 04/2011
1	Adenosine Triphosphatases (ATPase)IBA 03/2011
1	Tumor Biomarkers (Tumor Markers)IBA 12/2003
1	EnzymesIBA 12/2003